Kidron Miriam bought ORMP
December 31, 2025 · Form 4 insider transaction
Kidron Miriam bought 115,000 shares of Oramed Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
115,000
Price
$0.00
Total value
N/A
InsiderKidron Miriam
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 31, 2025
Filing dateJanuary 5, 2026
Shares owned after1,429,664
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents RSUs that will vest in quarterly installments over a three-year period starting January 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.